Contents

Previous

Next

The Health of Children and Young People

Tables

5.1 Proportion with respiratory symptoms and doctor-diagnosed asthma, by age and sex

5.2 Severity of respiratory symptoms and impact on everyday life in the last twelve months, by age and sex

5.3 General health and GHQ12, by wheezing in last twelve months, age and sex

5.4 Wheezing in the last twelve months and doctor-diagnosed asthma, by NS-SEC of household reference person, age and sex

5.5 Wheezing in the last twelve months and doctor-diagnosed asthma, by equivalised household income quintile, age and sex

5.6 Wheezing in the last twelve months and doctor-diagnosed asthma, by Government Office Region, age and sex

5.7 Wheezing in the last twelve months and doctor-diagnosed asthma, by Index of Multiple Deprivation (IMD), age and sex

5.8 Wheezing in the last twelve months and doctor-diagnosed asthma, by degree of urbanisation, age and sex

5.9 Wheezing in the last twelve months, by exposure to potential irritants, age and sex

5.10 Doctor-diagnosed asthma, by exposure to potential irritants, age and sex

5.11 Young adults' wheezing in the last twelve months, by own smoking status and sex

5.12 Wheezing in the last twelve months in children aged 8-15, adjusted for cotinine level, by own smoking status and sex

5.13 Wheezing in the last twelve months in children aged 0-15, by household size, age and sex

5.14 Wheezing in the last twelve months in children aged 0-15, by parental cigarette smoking, age and sex

5.15 Wheezing in the last twelve months in children aged 0-15, by parental wheezing, age and sex (year 2001 only)

5.16 Wheezing in the last twelve months in children aged 0-15, by parental asthma, age and sex (year 2001 only)  

5.17 Estimated odds ratio for wheezing in the last twelve months for children in two-parent households, by risk factors and sex (year 2001 only)

5.18 Estimated odds ratio for wheezing in the last twelve months for children in lone parent households (single mothers), by risk factors and sex (year 2001 only)

5.19 Estimated odds ratio for wheezing in the last twelve months for young adults, by risk factors and sex

5.20 Prevalence of respiratory symptoms and doctor-diagnosed asthma, 1995-1997 and 2001-2002, by age and sex

5.21 Response to IgE sample, by age and sex

5.22 Total IgE and percentage with house dust mite specific IgE greater than 0.4 kU/l, by age and sex

5.23 Geometric mean of total IgE, and percentage with house dust mite specific IgE greater than 0.4 kU/l, by respiratory symptoms, age and sex

5.24 Response to lung function measurement, by age and sex

5.25 Mean FEV₁, by height tertiles, age and sex

5.26 Mean FVC, by height tertiles, age and sex

5.27 Mean PEF, by height tertiles, age and sex

5.28 Height-adjusted mean FEV₁, by NS-SEC of household reference person, age and sex

5.29 Height-adjusted mean FEV₁, by equivalised household income quintile, age and sex

5.30 Height-adjusted mean FEV₁, by Government Office Region, age and sex

5.31 Height-adjusted mean FEV₁, by Index of Multiple Deprivation (IMD), age and sex

5.32 Height adjusted mean FEV₁, by wheezing in the last twelve months, age and sex

5.33 Height adjusted mean FEV₁, by doctor-diagnosed asthma, age and sex

5.34 Height adjusted mean FEV₁, by own smoking behaviour

5.35 Estimated differences from regression analysis in young adults' FEV₁ (adjusted for age and height), by smoking status, respiratory symptoms and sex

5.36 Height adjusted mean FEV₁, 1995-1997 and 2001-2002, by age and sex

Contents

Previous

Next